UnitedHealth’s troubles get worse, as 2025 outlook suspended and CEO steps down
UnitedHealth’s stock cuts the Dow’s price by more than 350 points, as care activity accelerates and Medicare costs remain higher than expected.
UnitedHealth’s stock cuts the Dow’s price by more than 350 points, as care activity accelerates and Medicare costs remain higher than expected.
